10月22日 - ** 莫德纳（Moderna） MRNA.O 股价下跌24%，至187.40美元
** 包括Reddit和X在内的社交媒体上有多条帖子指出，莫德纳与默克联合研发的癌症疫苗晚期临床试验数据可能已泄露 MRK.N
** 莫德纳与默克联合研发的癌症疫苗临床试验详细数据将于10月24日在ESMO大会上公布
** 本月早些时候，莫德纳取代华纳兄弟探索公司，正式纳入纳斯达克100指数
** 25家券商中有6家对莫德纳股票给出“买入”或更高评级，15家给出“持有”评级，4家给出“卖出”或更低评级；其目标价中位数为130美元——LSEG
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.